generic

(redirected from Generics)
Also found in: Dictionary, Thesaurus, Medical, Legal, Financial, Encyclopedia, Wikipedia.

generic

(dʒəˈnɛrɪk)
mod. cheap; plain; undesirable. I don’t want any old generic car, I want something with power and good looks.
References in periodicals archive ?
Assess leading generics companies, discovering their activities and outlooks
A new report by visiongain, a London-based business information company, predicts that world generic drug revenues will reach $137.
Washington Post, March 27: "Bush's AIDS Program Balks at Foreign Generics," by Stephen Brown.
MG: We see MANA in a unique position among generic suppliers.
Its manufacturer isn't concerned that the health plans' push for generics will woo consumers away from its popular anti-depressant.
Brand-name drugs that have a patent don't have an equivalent generic drug to compete with, so they're usually quite expensive.
Editor Ann Latner said the new title is designed to assist pharmacists "foster optimal utilization of generic drugs.
To be sure, Flanzraich faces many obstacles before generics take hold in the region.
The Thousand Oaks-based company, one of the nation's biggest health insurers, wants to reduce the cost of pricey prescriptions by subsidizing generic versions of popular medications like Prozac and Mevacor over their brand-name counterparts.
The Summit on Generics in Burkina Faso will be a place to share information among those seeking wider access to AIDS medicine.
This report reveals forecasted sales in the world generics market and in leading national markets, providing detailed quantitative and qualitative data.
While the benefits of authorized generics to the branded industry are clearly apparent, the attitude of the generics industry is determined by individual company strategy.
The Generics in the United Kingdom report includes detailed data on market size and segmentation, plus textual analysis of the key trends and competitive landscape, demographic information, and descriptions of the leading companies.
The Generics in France report includes detailed data on market size and segmentation, plus textual analysis of the key trends and competitive landscape, demographic information, and descriptions of the leading companies.
Competition between innovator companies and generics companies has never been higher as these groups battle to control drug markets; innovator companies continue to face unrelenting pressure from generics companies that want to invalidate drug patents and gain early market entry for their drugs.